Farag Kameel D.
SEC insider (Form 3/4/5 filer). CIK 0002093620. Interim CFO at Akari Therapeutics Plc (AKTX) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in TAMPA, FL.
Companies Farag Kameel D. has filed insider reports for
- Akari Therapeutics Plc (AKTX): Officer, Interim CFO
- BIOVIE INC. (BIVI): Director
Farag Kameel D.
CIK: 0002093620
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Aug 17, 2026AKTX
Akari Therapeutics Plc
AwardDirect1.7K shares at avg. $7.52$13K - Jul 16, 2026AKTX
Akari Therapeutics Plc
AwardDirect1.1K shares at avg. $11.50$13K - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirect1.4K shares at avg. $9.32$13K - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirect1.6K shares at avg. $8.28$13K - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirect2.5K shares at avg. $5.12$13K - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirect3.7K shares at avg. $3.49$13K - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirect1K shares at avg. $13.00$13K - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirect7.4K shares at avg. $3.74$28K - Jun 24, 2026AKTX
Akari Therapeutics Plc
AwardDirect1.2K shares at avg. $10.02$13K - Jan 5, 2026BIVI
BIOVIE INC.
AwardDirectStock Option (right to buy)
57.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 |  AKTX Akari Therapeutics Plc | Award | 1,728 | $7.52 | $12,995 | Direct |
| Jul 16, 2026 | AKTX Akari Therapeutics Plc | Award | 1,130 | $11.50 | $12,995 | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award | 1,395 | $9.32 | $13,001 | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award | 1,570 | $8.28 | $13,000 | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award | 2,539 | $5.12 | $13,000 | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award | 3,725 | $3.49 | $13,000 | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award | 1,000 | $13.00 | $13,000 | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award | 7,353 | $3.74 | $27,500 | Direct |
| Jun 24, 2026 | AKTX Akari Therapeutics Plc | Award | 1,248 | $10.02 | $12,505 | Direct |
| Jan 5, 2026 |  BIVI BIOVIE INC. | Award Stock Option (right to buy) | 57,500 | - | - | Direct |
1-10 of 15 transactions